中国血液净化 ›› 2014, Vol. 13 ›› Issue (04): 298-301.doi: 10.3969/j.issn.1671-4091.2014.04.002

• 临床研究 • 上一篇    下一篇

不同透析液钾离子浓度对透析前血钾及透析中心律失常的影响

刘日光,陈林,傅君舟,陈浩雄,周姗姗,陈磊   

  1. 广州市第一人民医院肾内科
  • 收稿日期:2012-12-26 修回日期:2013-12-02 出版日期:2014-04-12 发布日期:2014-04-12
  • 通讯作者: 傅君舟 fujzhou@163.com E-mail:kdoqi@hotmail.com

Effects of different dialysate potassium concentration on serum potassium and arrhythmia during hemodialysis

  • Received:2012-12-26 Revised:2013-12-02 Online:2014-04-12 Published:2014-04-12

摘要: 目的 探讨2种透析液钾离子浓度(dialysate potassium, KD)对透前血钾、高钾血症和透析中严重心律失常事件发生率的影响。方法 一个单中心、开放、自身对照试验,以一定标准纳入病人。于2010年5月某周在用KD =2.0mmol/L(简称 KD 2.0,以下类同)时为所有入组病人查透前血钾(0点)。之后调整至KD 2.5,分别于2周、4周、8周和12周查透前血钾。收集0点前后12周内透析中严重心律失常事件。结果 入组158例患者,2例退出,156例纳入分析。对比KD 2.0,使用KD 2.5虽然使透析中严重心律失常发生率有所下降,但差异无统计学意义(0.78% VS 0.47%,P=0.054)。在上调KD 两周后,患者透前平均血钾、高钾血症及严重高钾血症发生率均显著高于0点,分别为4.78±0.80 VS 4.51±0.79 mmol/L、26.9% VS 15.4%、9.6% VS 3.2%,P均<0.05。加予临床干预10周后,透前平均血钾仍高于0点,但高钾血症发生率可下降至0点水平。结论 使用KD 2.5比KD 2.0可使透析中严重心律失常发生率有下降趋势,但可导致透前高钾血症增多,后者可通过临床干预予以控制。

关键词: 肾透析, 透析液, 钾离子浓度, 心律失常, 心源性

Abstract: 0bjective To investigate the effect of dialysate potassium concentration (KD) on predialysis serum potassium and the incidence of hyperkalemia or arrhythmia during hemodialysis.Methods A single-center, open, self-controlled trial was conducted and patients were enrolled according to certain criteria. Predialysis serum potassium was examined when KD=2.0mmol/L (KD 2.0, the following was similar) was still used at one week in May 2010 (0 point). And then KD 2.5 was applied. Predialysis serum potassium was examined in 2, 4, 8, 12 weeks later, respectively. Serious arrhythmic events during hemodialysis were recorded in 12 weeks before and after 0 point.Results 158 patients were enrolled, 2 cases were exit and 156 cases were analyzed. Compared to KD 2.0, KD 2.5 could decrease the incidence of serious arrhythmia during hemodialysis, but the decline had not statistically significant difference (0.78% VS 0.47%,P=0.054).Predialysis mean serum potassium, incidence of hyperkalemia and severe hyperkalemia were significantly increased in 2 weeks after KD 2.5 applied (4.51±0.79 VS 4.78±0.80 mmol/L, 15.4% VS 26.9%, 3.2% VS 9.6%,P<0.05, respectively). After intervention for 10 weeks, the incidence of hyperkalemia dropped to the level of 0 point, although predialysis mean serum potassium was still significantly higher. Conclusions Compared to KD 2.0, KD 2.5 had the trends to decrease the incidence of serious arrhythmia during hemodialysis, but increased predialysis hyperkalemia which can be controlled through clinical intervention.

Key words: Renal dialysis, Dialysate, Potassium concentration, Arrhythmia, Cardiac